Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
How to Apply:
The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
External Deadline:
Friday, July 31, 2020
Agency:
Funding Source:
External
Funding Level:
Research